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Abstract 
 
Original Equipment Manufacturers (OEMs) in the German Medical Technology (MT) 
sector are facing a strong competition from low-wage countries developing, 
manufacturing, and distributing high-quality products globally. For this reason, 
organisations in this sector require orientation in the implementation of SCM policies to 
reduce operating cost and to create value for their customers. A multiple case study was 
conducted to identify SCM issues and best practices in this sector. This study contributes 
to healthcare operations management literature with a tailor-made assessment tool. Its 
findings offer new priorities for managers, particularly if they are contemplating a re-
engineering of their SCM strategies. 
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Introduction 
Medical technology is an innovative, fast-growing and promising industry, particularly 
so in Germany as it is the third largest market in the world behind the US and China 
(BVMed, 2018). Around 1,200 small and medium-sized enterprises (SMEs) represent 
the core of this sector (BMBF, 2017).  In 2017, the sales volume of MT organisations 
rose to 29.9 billion euros, with an export rate of 64% (BVMed, 2018).  
Despite this remarkable growth, the Medical Technology industry in Germany is 
faced with a number of challenges. Reportedly, Germany’s statutory health insurance 
fund (gesetzliche Krankenversicherung) has experienced funding difficulties, forcing 
administrators to reduce fees and thus expenditures on Medical Technology (Hartford, 
2014; Focus, 2016). Furthermore, manufacturers rely strongly on new product 
development to sustain or increase their market share, and with products having 
lifecycles not longer than 3 years, short development times and regulatory approvals 
become critical issues (Hempel, 2017; BVMed, 2018). Additionally, Chinese and Indian 
companies are also lined up to be frontrunners in terms of cost, workforce, and market 
capture, pressuring German manufacturers to produce and distribute cost-efficient 
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devices (Marucheck et al, 2011; Hempel, 2017). In this environment, the search for 
rationalisation potential becomes critical. Studies (J & M, 2010) show that a defined 
supply chain strategy often falls short in this sector. Major deficiencies reported are the 
absence of a formulated strategy, the lack of efficient planning and coordination 
processes, along with unreliable sales forecasts. 
In this paper, the authors investigate multiple cases of OEMs involved in Medical 
Technology Supply Chains (MTSCs) in Germany and use the results of the analysis to 
identify both areas at which these organisations excel as well as areas of improvement 
which require addressing during the design and operation of their SCM strategies. This 
paper builds on previous research conducted by the authors (Garcia-Villarreal et al, 
2019) and is organised as follows: first, a review of the literature is reported. Then, the 
research aim and focus are formulated, followed by the justification of the selected 
methodology and case study design. Next, the findings are presented and analysed. 
Finally, this paper concludes by stating the implications for theory and management 
practice along with research limitations and avenues for further research. 
 
Literature review 
 
Healthcare & Medical Technology Supply Chains 
Supply chain management as an area in operations management literature is extremely 
well served whereas there is a real dearth regarding its focus on medical technology 
supply chains and their agility as exemplified by recent literature (Gligor, 2014; Mandal, 
2017). Mentzer et al (2001, p. 4) define supply chains as a “set of three or more entities 
directly involved in the upstream and downstream flow of products, services, finances, 
and information from a source to the customer”. There are three major players in the 
Medical Technology supply chain: producers (product manufacturers), purchasers (group 
purchasing organisations, or GPOs, and wholesalers/distributors), and healthcare 
providers (hospital systems and integrated delivery networks, or IDNs) (Burns et al, 
2002).  
The manufacturers (producers) in the supply chain can be broadly classified into three 
groups namely, pharmaceutical, medical-surgical, and device manufacturers, the latter 
being the object of this study. Their products are then purchased by GPOs, wholesalers, 
distributors and in some cases independent contractors, and then delivered to providers 
like hospitals, integrated delivery networks (IDNs), physicians (individual clinics) and 
pharmacies. Customers (payers) in this supply chain are local governments, employers, 
and individuals. They pay the providers through fiscal intermediaries like insurers, 
health maintenance organisations (HMOs) and pharmacy-benefit managers. Smith et al 
(2012) provides a detailed view of the medical devices supply chain, in which the main 
product flows between the key players are clearly represented (see Figure 1), underlining 
the heavy influence of intermediaries or third-party players. 
Studies by Burns (2000), Dacosta-Claro (2002), J and M Research (2010), and Mayer 
(2013) indicate that a significant portion of the costs associated with supply chains in 
the health care sector can be reduced by adopting strategies already deployed by the 
industry sector (e.g. automotive). For this reason, identifying areas of opportunity and 
areas managed successfully by these organisations becomes very important. 
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Figure 1: Detailed view of the medical devices supply chain (Smith et al, 2012, p. 3) 
 
Review of SCM assessment tools available in academic literature 
The literature review identified a number of tools available for assessing the performance 
of logistics and manufacturing companies within their supply chains, which are briefly 
presented and discussed in this section.  
Tummala et al (2006) conducted a survey research with top and middle managers 
within a large enterprise as respondents in order to examine operational issues 
concerning success factors that are necessary when implementing SCM plans in one 
large manufacturing firm. Dimensions for evaluation were ‘customer-supplier 
relationship’, ‘information and communication technology (ICT)’, ‘re-engineering 
material flow’, ‘creating corporate culture’, and ‘performance measurement’. Their 
study revealed that resource allocation could be enhanced in areas such as information 
systems, goal-setting, training personnel, and aligning SCM initiatives with current 
priorities and committed resources in that particular organisation. Although this 
assessment tool did focus on many factors related to logistics and SCM, neither ‘make’  
(e.g. manufacturing issues) nor ‘return’ processes (e.g. reverse logistics, green supply 
chain) were considered in it.  
Gunasekaran and Ngai (2003) conducted an interview-based case study on a small 
third-party logistics (3PL) company in Hong Kong that had been successful in its overall 
business performance and in satisfying its customers. In this study, they designed a 
framework for developing an efficient 3PL system. While their assessment tool appeared 
easy to use, it only included five major dimensions for evaluation (‘strategic planning’, 
‘inventory management’; transportation planning’; capacity planning’; and 
‘information technology’). It can be noted that this assessment tool was not intended for 
manufacturing firms, but rather for 3PL companies, as neither of the dimensions 
considered any form of evaluation criteria aimed at identifying issues in the 
development, production, and quality assurance of items (‘make’ processes).  
Finally, Thakkar et al (2011) used a case study approach to identify issues in SMEs 
of Indian origin. The assessment tool developed for this study offered a thorough 
approach,  consisting of the evaluation of Critical Success Factors (CSFs) ‘effective 
partnership’, ‘improve communication’, ‘logistics integration’, ‘supply chain business 
strategy’, ‘buyer-supplier relationship’, ‘effective  planning and control’, ‘trust  among  
supply chain  partners’, and ‘availability of performance management tools’. However, 
the dimensions under review appear to be too much leaned against the ‘source’ side of 
the business.  
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Research methodology 
The research objective of this study is to explore key areas of improvement of German 
MT OEMs during the design and operation of their supply chain strategies. Therefore, 
this study was driven by the following research question: 
• What are the strengths and weaknesses of German MT OEMs in regard to their 
supply chain strategies? 
In order to answer this question, an exploratory research  with  a  multiple  case  study  
approach was selected for three reasons: (1) the literature review revealed limited 
insights concerning weaknesses and strengths in SCM practices in the MT sector. In 
such an embryonic research field, a qualitative research provides better means to identify 
patterns and develop theory (Edmondson and McManus, 2007). (2) As  the researchers  
were  able  to  interact  with  respondents, perspectives  were  better  understood  (Boyer  
and  Swink,  2008). (3) Case studies encourage management involvement, which helped 
this research to generate managerially relevant knowledge. Established methodological 
guidelines for case study research were observed (Eisenhardt, 1989; Robson, 2011; Yin, 
2009). Fourteen in-depth case studies of manufacturing organisations were conducted to 
obtain a greater understanding of the main issues of German MTSCs (see Table 1). In 
order to enrich the results, the selected case study organisations were of different 
subsectors (e.g. laboratory equipment manufacturing, electromechanical MT, non-active 
implantable technology, etc.) and sizes, with eight Large Enterprises (LEs) and six 
SMEs participating. 
 
Table 1: Summary of the respondent demographics 
 
Nr. Company Classification according 
to the GMDN Agency 
(2012)1 
Position of respondent Company size 
according to IfM 
(2017) 2 
Number of 
employees 
1 A Laboratory equipment Vice President of Supply Chain 
Small and Medium 
Enterprise (SME) 300 
2 B Electromechanical medical technology 
Vice President Global 
Logistics Large Enterprise (LE) 53 000 
3 C Electromechanical medical technology 
Manager of Logistics 
Planning Large Enterprise (LE) 12 500 
4 D Non-active implantable technology 
Director of Supply Chain 
Management Large Enterprise (LE) 3 400 
5 E Electromechanical medical technology Head of Supply Chain Large Enterprise (LE) 6 000 
6 F Reusable instruments Manager of Logistics Planning Large Enterprise (LE) 4 400 
7 G Hospital hardware Vice President of Global Logistics Large Enterprise (LE) 6 300 
8 I Non-active implantable technology 
Vice President of Supply 
Chain 
Small and Medium 
Enterprise (SME) 180 
9 J Electromechanical medical technology 
Head of Supply Chain 
Operations 
Small and Medium 
Enterprise (SME) 400 
10 K Diagnostic and therapeutic radiation technology 
Director of Supply Chain 
Management Large Enterprise (LE) 49 000 
11 L Single use technology Director of Supply Chain Small and Medium Enterprise (SME) 500 
12 M Healthcare facility products and systems adaptations Head of Supply Chain 
Small and Medium 
Enterprise (SME) 200 
13 N Anesthetic and respiratory technology 
Director of Purchasing, 
Global Supply Chain 
Small and Medium 
Enterprise (SME) 200 
14 O Hospital hardware Head of Outbound Logistics Large Enterprise (LE) 15 200 
1 = (GMDN-Agency, 2012) 
2= (Institut für Mittelstandsforschung (IfM), Bonn, 2017) 
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A suitable assessment tool was required for this study. The literature review identified 
and discussed available assessment tools, which were deemed too simplistic, too 
complex for practitioners to use regularly, missing processes featured in the SCOR-
Model  (Supply Chain Council, 2008), or not suited for the context of this study. For 
these reasons, an assessment tool was designed, piloted, and implemented to identify 
strengths and weaknesses of SCM strategies in the case organisations (see Figure 2). The 
theoretical foundations of this tool as well as the dimensions under review are based on 
identified CSFs by the authors in previous research (Garcia-Villarreal et al, 2019). 
 
 
 
Figure 2. Example of mapping results of Case Organisation L using the assessment tool  
for this study 
 
Research findings 
This study identified areas where case organisations excelled at their SCM strategies as 
well as areas requiring immediate attention by SCM practitioners. These are reported 
here. 
 
Strengths in SCM practices of MT organisations 
Strengths of MT organisations (predominantly LEs) were found in four areas: (1) the 
design of OEMs’ supply chain capabilities according to their customer value 
propositions; (2) the deployment of intelligent product design; (3) the use of ‘track and 
trace’ systems to increase supply chain visibility; (4) an expansion of the role of OEMs 
to deliver more value for their customers.  
In terms of the design of the supply chain capabilities according to their customer value 
propositions, this study identified three fundamental approaches: a flow-oriented 
approach, a batch-oriented approach, or a combination of both. The flow-oriented supply 
chain is set up on the basic condition of a quite fixed series of repetitive transactions 
(material, information, payments). Case Organisations A, E, L, and N had a flow-oriented 
approach to their supply chains. What these companies had in common is the production 
of mass articles with a low degree of variation and in high volumes.  These companies 
strived to reduce costs in their supply chains by improving their standard, repetitive 
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operations. Conversely, Case Organisations D, M, and I had adopted a batch-oriented 
supply chain strategy for their operations. These companies had three things in common: 
they produced niche products according to customer specifications, they did not 
manufacture these products in high volumes, and they sold these items at a high price. 
The supply chain required to carry these products needed several arrangements: 
Manufacturers had to interact with a larger number of raw material suppliers; each 
contract with hospitals or clinics needed to be individually priced and logistics details had 
to be arranged individually; instead of a continuing number of shipments, there was a 
limited number of batch deliveries. 
The basis for the economic success of German MT is the broad range of innovative 
products it creates, with about a third of its revenues generated from products that are less 
than three years old (BMBF, 2015). For this reason, the product development process 
becomes crucial for the supply of innovative products to their customers (Medina et al. 
2013). Case organisations in the study reported a transition from an inwardly-oriented 
approach to product design (first developing a product then searching for a market) to a 
more customer-oriented approach (understanding customer needs and developing 
products thereafter). Involving surgeons in the innovation process proved beneficial to 
OEMs, as development, product test, and regulatory approval times could be reduced 
(Lettl, 2013), while increasing product variety to address users’ specific needs (Al‐Zu'bi 
& Tsinopoulos, 2012). Given the importance of the role of users in the design of products, 
Case Organisation D cooperates actively with surgeons in the design of medical devices 
and names their finished products after the physician that inspired or co-designed them. 
Activities in product development process have an influence on the performance of other 
organisational functions, such as procurement, manufacturing, marketing and sales, and 
service. Case Organisation A launched a project to standardise information flows between 
sales, product development, and procurement in order to reduce the risk of dependency 
to niche suppliers. These efforts enhanced their material availability while reducing the 
risk of material obsolescence. Case Organisation J analysed their product portfolio in an 
effort to standardise their raw materials and their part numbers, with the effect of 
decreasing their supplier base and streamlining their purchasing, order picking, and 
assembly processes. Case Organisation D focused on reducing manufacturing costs 
(technology, methods, and materials) through a re-examination of their product portfolio. 
Finally Case Organisation H launched a project to improve their product update services 
in order to cut manufacturing, procurement, inventory, and after-sales costs.    
Several organisations in this study have made supply chain visibility a top priority in 
their agendas and have made significant investments in this area. One major reason is to 
fight product counterfeits. Another reason is that their customers require status reports 
about shipments in real time: hospitals are increasingly under pressure to schedule both 
patients and surgeries more efficiently, both for humanitarian and economic reasons, as 
costly hospital equipment (e.g. computer tomographs) cannot afford downtimes. 
Therefore, the recipients are requiring effective “track and trace” instruments to monitor 
the shipping status in real-time. Clinics expect real-time information, especially for 
unplanned maintenance work. At Case Organisation K, 30 to 50 per cent of the 
maintenance services are unplanned. Case Organisation K needs to supply 98 per cent of 
all spare part orders within 24 hours – and, if possible, in all 132 countries covered by the 
manufacturer. This poses a challenge for freight forwarders: if the shipment is half an 
hour too late, it is already considered late. Therefore, Case Organisation K has been 
working with third party logistic providers to digitalise their distribution chain. In order 
to enhance their response rate, Case Organisation K defined milestones with the freight 
forwarders along the supply chain. Once a milestone had been reached during the 
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transportation of products, it was the freight forwarder’s responsibility to deliver a push 
message to both manufacturers and recipients. 
One of the largest cost items for hospitals and clinics, as reported by some case 
organisations, is the management of products such as endoprosthetics, pacemakers or 
surgical covers. Some case organisations are reportedly working to improve hospitals’ 
operational procedures in the sterilisation departments, in operating rooms, as well as in 
the hospitals’ internal logistics.  Effects of these projects are shorter throughput times for 
the supply of instrument trays to operating rooms, reduced stocks of instrument trays in 
storage rooms, and streamlined logistics processes for hospitals. Additionally, Case 
Organisation K reported working on taking over the repair management functions of 
hospitals in order to consolidate internal cost and reduce the replacement rates of 
instruments.  In the same context, Case Organisations D and K have been working on 
expanding their capacities for the repair of used instruments, in order to reduce the 
hospitals’ replacement rates. For this reason, it is expected that OEMs can gain a 
competitive advantage by working together with their customers to streamline their 
internal processes and to reduce managerial efforts. 
 
Weaknesses in SCM practices of MT organisations 
In terms of the main SCM issues in this sector, this study identified four areas where the 
severity of SCM issues is critical: (1) a lack of rigour in the deployment of sales and 
operations planning; (2) poor first-tier integration; (3) distribution networks not set up 
according to customer needs of product availability; and (4) a strong emphasis on quick 
wins and quarterly savings hindering change at management level.  
Regardless of their products and services or their size, 11 (C, E, F, G, O, A, I, L, J, M, 
N) of the 15 case organisations in the study have experienced some form of disruption in 
their respective supply chains that has hindered their ability to harmonise customer 
demand with production and distribution capacities. Reasons for these disruptions are, 
among others, a low level of trust, integration, and information sharing between OEMs 
and both customers and suppliers; and a lack of rigour in the deployment of their existing 
Sales and Operations Planning (S&OP) process, fostered by conflicting target and 
performance appraisal systems within the organisations and developing counter-
productive behaviours such as silo-thinking within organisational departments. This issue 
has particularly affected SMEs, which, in the absence of joint planning with customers, 
has made the position of their supply chains vulnerable. 
Several organisations reported having issues related to their current procurement 
strategies and approaches. Similar patterns were identified for both LEs and SMEs: LEs 
reported on having adopted select procurement strategies (Kanban, Vendor-Managed 
Inventory (VMI), Electronic Data Interchange (EDI), Just in Time (JIT)) and have come 
to expect their supplier base to become JIT suppliers, but in the absence of cross-
functional integration within the OEMs, the implementation of these strategies appeared 
to be disjointed and did not lead to a full utilisation of their systems’ capabilities. In 
addition, approaches to procurement of Case Organisations E, G, and O seemed to be 
one-sided, apparently seeking no win-win situations with suppliers and thus hindering 
collaboration. In contrast, issues shared by SMEs range from underprivileged power 
relationships with suppliers (cases M and L), inaccurate master data hindering an efficient 
information exchange with suppliers (cases J, A, N), and raw material shortages due to 
fluctuating prices and an almost exclusive focus on local sourcing (cases I, L, M). 
Evidence of this disconnect in the relationship with suppliers could be found in the 
presence of the high raw material inventories and slow turnover ratios for almost all cases 
referenced above. 
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Additionally, Cases B, G, O, A, L, I, J, and I shared that their distribution network was 
not set up according to customer needs of product availability. Therefore, these 
companies were forced to ship their products via express delivery at high cost. In the case 
of Case Organisations I, L, and N, this is partly explained due to the fact that reportedly, 
the design of efficient logistics structures had not been focus of much work, as before the 
crisis in 2009, there had not been a need to change.  Now these companies are catching 
up with several concepts well established in the automotive industry. For instance, Case 
Organisations L, J, M, and N – all SMEs -, are currently embarking on projects of their 
own seeking to integrate external logistics service provides. They believe that outsourcing 
distribution will help them focus on their core competencies, access new markets, 
optimise transport routes, and save them the time and money they would have invested 
in setting up their own distribution facilities. 
Finally, it appeared that several managers have merely added the term ‘supply chain’ 
to their jargon without adopting a SCM mind-set. A strong emphasis on quick wins 
seemed to limit the ability of several case organisations to establish appropriate processes 
and relationships or to anchor them in the organisational culture. For instance, Case 
Organisations G and O seemed to have organised all their SCM activities around their 
logistics and customer service activities, yet these efforts were focused primarily on direct 
‘A’ customers and were reactive in nature, neglecting ‘B’ customers with the potential to 
transform into ‘A’ customers. While all respondents believed that SCM could assist their 
respective companies to succeed in their marketplace, they did recognise the difficulty to 
bridge organisational boundaries in their relationship with suppliers. In this sense, the 
procurement strategies of several case organisations (e.g. Cases E, O, G) appeared to be 
one-sided, seeking no win-win situation, thus hindering collaboration.  
Furthermore, several case organisations seemed willing to invest in technological 
solutions to solve operational challenges. Respondents I, M, and L made a case for 
investments on better information technologies hoping that this would provide their 
supply chains with substantial improvements in terms of efficiency, collaboration, and 
responsiveness. While this may be partially true, some respondents warned that 
improving collaboration between stakeholders required more than an enhanced 
information platform. Therefore, they had been working with core first-tier suppliers and 
customers to (1) define the boundaries and strength of their relationships; (2) establish 
communication requirements; and (3) select appropriate technologies based on an 
analysis of these requirements.  
Only a few companies have established a SCM culture that promotes fact-based 
decision-making. For instance, case organisations such as C and D had been installing 
common goals in SCM for all departmental functions within their organisation. 
Furthermore, these organisations have understood that cultures change slowly and that 
changing long-standing ways of doing things require appropriate strategies and serious 
commitment from management. Therefore, they have been involving owners, senior 
managers, and middle management in transformation projects, as they understood that a 
real change could only occur with direct involvement of stakeholders.  
In this context, the middle management seemed to have a key role both as an 
intermediary between the goals of senior management and the priorities of the operational 
staff, and as an agent for sustainable changes in operational policies. For these companies, 
SCM was not seen a project but as a long-term journey. 
 
Conclusion 
The objective of this study was to identify strengths and weaknesses of current SCM 
practices of OEMs in the German MTSC sector. The interactions with fourteen OEMs 
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have helped to identify both areas where these organisations excel and areas where the 
severity of the issues requires immediate attention.  
Areas where MT organisations excel are (1) the design of OEMs’ supply chain 
capabilities according to their customer value propositions; (2) the deployment of 
intelligent product design to reduce sourcing costs and to build stronger partnerships with 
physicians; (3) the enhancement of supply chain visibility with “track and trace” 
systems; and (4) designing and implementing individual concepts for supply and 
management of medical devices for hospitals and clinics.  
On the other hand, major issues identified in this sector include: (1) a lack of rigour in 
the deployment of sales and operations planning; (2) poor first-tier and second-tier 
integration; (3) misaligned distribution networks; and (4) a strong emphasis on quick wins 
and quarterly savings hindering change at management level.  
This research contributes to knowledge in the form of an assessment tool that identified 
strengths and weaknesses of SCM strategies in the MT sector. Although a number of tools 
available for assessing the performance of organisations within their supply chains were 
identified, these appeared to be either too simplistic, too complex for practitioners, 
lacking important dimensions for evaluation, or not suited for this research context. In an 
effort to fill this gap, this study developed its own tool, providing an approach to 
evaluation that considers the five basic business processes required to satisfy customer 
demand (‘Plan’, ‘Source’, ‘Make’, ‘Deliver’, ‘Return’)  (Supply Chain Council, 2008). 
Researchers can use it as a means to conduct further research work in other contexts. 
Additionally, managers of MT OEMs who wish to develop or restructure their 
organisations’ SCM policies can benefit from this tool, as it provides them with an 
orientation for resource allocation. The main limitation is that this tool is tailor-made for 
organisations in the MT sector. Although this is a limitation, it does however give 
evidence to how closely this tool is designed for the sector in focus, as it considered this 
industry’s characteristics. Further research work can use this assessment tool to test its 
applicability in other contexts other than the German MT sector.  
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